|George Washington Carver Is Not Liable For Peanut Butter Allergies (he didn't even invent it)|
In Part 1, I introduced this topic after opening a piece of mail telling us that a $500-something dollar epipen we own had reached its expiration date. It made me curious whether the "obsolescence" of the pharmaceuticals equated to actual risk, and made me think about the different financial implications for wealthy, poor, stockholders, etc. And how the psychology of "greed and fear" is used as a persuader to advance the interests of those parties. From Part 1:
In the case of an epi-pen, "less effective" is certainly a concern if you can afford a new one. But if my kid starts to suffer a life-threatening peanut allergy reaction, I'm not going to check the date on his epi-pen.Hint: No
What about "elective upgrade"? Can I sell my expired epi-pen, and buy a new one to satisfy my risk averse kin? That reduces MY liability (to my son), but is my liability somehow "externalized" to poor people?
But let's see how the Policy On Pharma Storage or Disposal (not recycling) is covering the exits.